7.10 Measles, Febrile Rashes and Malaria After Travel
Key Takeaways
Suspected measles in Ireland requires immediate telephone notification and precautions while testing and contact assessment proceed.
Urgently investigate possible malaria after relevant travel even if prophylaxis was taken. Repeat microscopy when suspicion persists.
Falciparum malaria with organ dysfunction requires immediate hospital treatment and specialist management.
Recognise a febrile rash and act on suspected measles
Ask about vaccination records, exposure to an ill contact, travel, symptom order and when and where the rash started. Check breathing, circulation and mental state. Measles often begins with fever, cough, coryza and conjunctivitis. A maculopapular rash commonly starts on the face and spreads down. Koplik spots may occur but are easy to miss. An immunocompromised patient may present differently. Clinical appearance alone cannot confirm or exclude measles.
| Pattern | Immediate assessment |
|---|---|
| Fever with cough, coryza and conjunctivitis, followed by a spreading rash | Consider measles and use the Irish infection-control and notification pathway if clinically suspected. |
| Fever subsides as a blanching rash appears in an otherwise improving young child | Roseola is one possibility. Reassess if the child remains unwell or the clinical course changes. |
| Bright cheeks followed by a rash on the limbs | Consider parvovirus B19 and assess significant exposure in pregnancy or other vulnerable contacts. |
| Generalised maculopapular rash with postauricular, occipital or cervical lymphadenopathy | Consider rubella. Arrange laboratory confirmation and assess possible exposure in pregnancy with Public Health. |
| Rapid illness with a non-blanching rash, impaired perfusion or altered consciousness | Assess immediately for serious infection, including meningococcal disease, and treat under the emergency pathway. |
For suspected measles, arrange assessment without using a shared waiting area and alert a receiving service before transfer. Separate a patient who has already arrived and use appropriate airborne precautions and fit-tested respiratory protection according to HSE policy. Notify the Medical Officer of Health by telephone immediately on suspicion, then complete the applicable reporting. Arrange surveillance oral fluid for testing by the National Virus Reference Laboratory, with other specimens as advised. Testing and contact assessment can proceed alongside acute care. Distinguish reporting a suspicion from confirmation on laboratory results. Assess for complications such as pneumonia, dehydration and encephalitis and organise emergency clinical care where indicated.
Under the HPSC guideline, infectiousness typically extends from four days before rash onset to the end of four full days after the rash appears. Some immunocompromised people can remain infectious longer. Public Health assesses contacts, including vaccination records and vulnerability. In a susceptible eligible healthy contact, MMR within 72 hours can reduce risk. A susceptible infant, pregnant person or immunocompromised contact needs time-sensitive individual assessment, including whether immunoglobulin is indicated. In selected high-risk groups it can be given within six days of exposure. The post-exposure route and product depend on the group. MMR is a live vaccine and contraindicated in pregnancy and severe immunosuppression. Keep routine immunisation and time-limited post-exposure actions distinct.
HPSC Irish measles guideline, January 2026 · HSE AMRIC healthcare precautions · HPSC infectious disease notification.
A child with rubella may have little fever or systemic disturbance. The rash overlaps with other conditions, so seek laboratory confirmation through the Public Health and laboratory pathway rather than relying on appearance. Acute and congenital rubella are notifiable in Ireland. Review vulnerable contacts, especially possible exposure during pregnancy, promptly. Consider congenital infection when there is compatible maternal exposure and findings such as hearing impairment, cataracts or congenital heart disease. Arrange paediatric and Public Health assessment in that setting. Follow the current Irish childhood and catch-up immunisation schedule for prevention.
HPSC rubella clinical information and notification · Irish rubella case definitions.
An unimmunised 8-year-old arrives at a GP practice with fever, cough, coryza, red eyes and a new rash spreading from the face. The child is clinically stable. A pregnant household contact has no documented immunity. What should the practice do now?
Keep the child in the shared waiting area until a serum test is available
Give the pregnant contact MMR immediately and delay assessment of the child
Separate the child, use airborne precautions, telephone Public Health now and arrange appropriate samples and contact assessment
Wait until four days after the rash before contacting Public Health
Investigate fever after travel when malaria is possible
Take an itinerary with dates and locations, kind of accommodation, mosquito exposure, chemoprophylaxis and adherence, other exposures and relevant outbreaks. Fever after travel to a malaria-risk area requires urgent consideration of malaria even when prophylaxis was taken. Headache, chills, muscle aches or gastrointestinal symptoms can occur without a repeating fever pattern. Early illness may resemble common bacterial or viral infection. If the history raises concern for a high-consequence infection, apply the current HPSC risk and infection-control pathway and coordinate testing with the receiving and laboratory teams.
Arrange urgent thick and thin blood films and discuss testing directly with the laboratory, including out of hours. The thick film aids detection and the thin film helps determine species and parasite burden. A rapid antigen test can support the diagnosis when used alongside microscopy. A single negative test does not exclude malaria if suspicion persists. Arrange serial films with the receiving team and laboratory when suspicion persists. The St James’s Hospital laboratory advises repeat sampling at six- to twelve-hour intervals in this setting; follow the receiving laboratory’s protocol. Check glucose, full blood count, kidney and liver function and other severity markers as indicated, and investigate other causes in parallel. Malaria is notifiable in Ireland.
Impaired consciousness, seizures, shock, acidosis, acute kidney injury or serious respiratory failure can indicate severe disease. Escalate immediately to infection and critical care teams. Start parenteral treatment without waiting for confirmation when severe malaria is strongly suspected. The current WHO guideline recommends parenteral artesunate for at least 24 hours and until oral medication is tolerated. The EU-authorised IV product requires completion with an appropriate oral combination course and surveillance for delayed haemolysis for four weeks after starting therapy. Follow the relevant product and specialist pathway. In uncomplicated disease a specialist chooses therapy by species, acquisition, age, pregnancy and previous prophylaxis. P. vivax and P. ovale may require later treatment of dormant liver stages after appropriate G6PD assessment.
HPSC malaria · St James’s Hospital malaria laboratory pathway · HPSC high-consequence infection risk guidance · WHO malaria guideline, September 2026 · EMA IV artesunate product information.
Plan prevention before departure
Review countries and stopovers, dates, rural exposure, accommodation and activities. Ask about pregnancy, immunosuppression, age, medicines and prior vaccinations. Review the routine schedule and match further vaccines to the current itinerary, destination advice and the traveller’s risk. A vaccine recommended for protection and a certificate required for entry are separate decisions. Assess live-vaccine suitability or refer for specialist travel advice if there is a contraindication or uncertainty. Arrange advice early because protection or a certificate may take time, and still assess people who present late.
For malaria risk, combine appropriate chemoprophylaxis when indicated with mosquito avoidance, such as repellent, clothing and bed nets. Check medicine eligibility and explain start, end and missed-dose instructions for the specific product. Counsel about safe food and water. Explain how to obtain care abroad and advise urgent assessment for fever during or after travel, disclosing the itinerary and any prophylaxis.
NIAC travel immunisation chapter and current chapter index · Irish travel advice · WHO malaria guidance.
An adult returns to Ireland after working in a malaria-risk area. He had taken prescribed prophylaxis. He presents with fever, a Glasgow Coma Scale score of 10 and acute kidney injury with creatinine 310 µmol/L. Urgent microscopy reports P. falciparum, and no alternative cause for the organ dysfunction is apparent. Resuscitation and critical care escalation are underway. Which antimalarial plan is appropriate?
Withhold antimalarial treatment until the next film quantifies parasites again
Start urgent IV artesunate with specialist input and plan a complete oral combination course once clinically appropriate
Give oral prophylaxis again as the only treatment
Wait for a cyclic fever pattern before treating
A traveller asks about a six-week rural stay in a malaria-risk area. They will visit family, have not brought vaccination records and do not know the requirements for a stopover. What should the pretravel consultation do?
Give the same vaccines and malaria medicine to everyone visiting the country
Check itinerary, vaccine history and individual risk, verify current entry rules and combine indicated prophylaxis with bite prevention and return advice
Give chemoprophylaxis alone because it removes the need for mosquito avoidance
Wait until after the trip to check routine vaccination and advise only if symptoms occur
An otherwise well unvaccinated child develops a generalised maculopapular rash with postauricular and occipital lymphadenopathy after international travel. A pregnant household contact may be susceptible. Rubella is among the possible diagnoses. What is the best next step?
Diagnose rubella by its rash alone and give live MMR to the pregnant contact
Reassure without investigation because the child is not very unwell
Arrange testing for suspected rubella through the local pathway and promptly contact Public Health about notification and the potentially susceptible pregnant contact
Delay the contact assessment until the child develops a high fever
Sections you finish are checked off in the contents.